Safety  ||| S:0 E:7 ||| NNP
and  ||| S:7 E:11 ||| CC
acceptability  ||| S:11 E:25 ||| NN
of  ||| S:25 E:28 ||| IN
intrauterine  ||| S:28 E:41 ||| JJ
balloon  ||| S:41 E:49 ||| NN
stent  ||| S:49 E:55 ||| VBZ
used  ||| S:55 E:60 ||| VBN
in  ||| S:60 E:63 ||| IN
uterine  ||| S:63 E:71 ||| NN
after  ||| S:71 E:77 ||| IN
hysteroscopic  ||| S:77 E:91 ||| JJ
adhesiolysis  ||| S:91 E:104 ||| NN
to  ||| S:104 E:107 ||| TO
prevent  ||| S:107 E:115 ||| VB
adhesion  ||| S:115 E:124 ||| JJ
reformation  ||| S:124 E:136 ||| NN
To  ||| S:136 E:139 ||| TO
evaluate  ||| S:139 E:148 ||| VB
the  ||| S:148 E:152 ||| DT
safety  ||| S:152 E:159 ||| NN
and  ||| S:159 E:163 ||| CC
acceptability  ||| S:163 E:177 ||| NN
of  ||| S:177 E:180 ||| IN
COOK  ||| S:180 E:185 ||| NNP
intrauterine  ||| S:185 E:198 ||| JJ
balloon  ||| S:198 E:206 ||| NN
stent  ||| S:206 E:212 ||| NN
in  ||| S:212 E:215 ||| IN
uterine  ||| S:215 E:223 ||| NN
for  ||| S:223 E:227 ||| IN
one  ||| S:227 E:231 ||| CD
week  ||| S:231 E:236 ||| NN
after  ||| S:236 E:242 ||| IN
hysteroscopic  ||| S:242 E:256 ||| JJ
adhesiolysis ||| S:256 E:268 ||| NN
.  ||| S:268 E:270 ||| .
A  ||| S:270 E:272 ||| DT
total  ||| S:272 E:278 ||| NN
of  ||| S:278 E:281 ||| IN
79  ||| S:281 E:284 ||| CD
females  ||| S:284 E:292 ||| NNS
with  ||| S:292 E:297 ||| IN
moderate-severe  ||| S:297 E:313 ||| NNP
Asherman  ||| S:313 E:322 ||| NNP
syndrome  ||| S:322 E:331 ||| NN
undergoing  ||| S:331 E:342 ||| VBG
hysteroscopic  ||| S:342 E:356 ||| JJ
division  ||| S:356 E:365 ||| NN
of  ||| S:365 E:368 ||| IN
intrauterine  ||| S:368 E:381 ||| JJ
adhesion  ||| S:381 E:390 ||| NN
were  ||| S:390 E:395 ||| VBD
enrolled  ||| S:395 E:404 ||| VBN
from  ||| S:404 E:409 ||| IN
June  ||| S:409 E:414 ||| NNP
2012  ||| S:414 E:419 ||| CD
to  ||| S:419 E:422 ||| TO
December  ||| S:422 E:431 ||| NNP
2013 ||| S:431 E:435 ||| CD
.  ||| S:435 E:437 ||| .
They  ||| S:437 E:442 ||| PRP
were  ||| S:442 E:447 ||| VBD
divided  ||| S:447 E:455 ||| VBN
into  ||| S:455 E:460 ||| IN
two  ||| S:460 E:464 ||| CD
groups  ||| S:464 E:471 ||| NNS
of  ||| S:471 E:474 ||| IN
intrauterine  ||| S:474 E:487 ||| JJ
balloon  ||| S:487 E:495 ||| NN
stent  ||| S:495 E:501 ||| NNS
( ||| S:501 E:502 ||| -LRB-
n  ||| S:502 E:504 ||| CD
=  ||| S:504 E:506 ||| SYM
51 ||| S:506 E:508 ||| CD
)  ||| S:508 E:510 ||| -RRB-
and  ||| S:510 E:514 ||| CC
tailed  ||| S:514 E:521 ||| JJ
intrauterine  ||| S:521 E:534 ||| JJ
contraceptive  ||| S:534 E:548 ||| JJ
device  ||| S:548 E:555 ||| NN
( ||| S:555 E:556 ||| -LRB-
n  ||| S:556 E:558 ||| CD
=  ||| S:558 E:560 ||| SYM
28 ||| S:560 E:562 ||| CD
) ||| S:562 E:563 ||| -RRB-
.  ||| S:563 E:565 ||| .
The  ||| S:565 E:569 ||| DT
sterile  ||| S:569 E:577 ||| JJ
swabs  ||| S:577 E:583 ||| NN
were  ||| S:583 E:588 ||| VBD
taken  ||| S:588 E:594 ||| VBN
from  ||| S:594 E:599 ||| IN
cervical  ||| S:599 E:608 ||| JJ
canals  ||| S:608 E:615 ||| NNS
for  ||| S:615 E:619 ||| IN
bacterial  ||| S:619 E:629 ||| JJ
culture  ||| S:629 E:637 ||| NN
by  ||| S:637 E:640 ||| IN
the  ||| S:640 E:644 ||| DT
same  ||| S:644 E:649 ||| JJ
microbiologist ||| S:649 E:663 ||| NN
.  ||| S:663 E:665 ||| .
Each  ||| S:665 E:670 ||| DT
patient  ||| S:670 E:678 ||| NN
in  ||| S:678 E:681 ||| IN
balloon  ||| S:681 E:689 ||| NN
group  ||| S:689 E:695 ||| NN
was  ||| S:695 E:699 ||| VBD
requested  ||| S:699 E:709 ||| VBN
to  ||| S:709 E:712 ||| TO
answer  ||| S:712 E:719 ||| VB
a  ||| S:719 E:721 ||| DT
questionnaire  ||| S:721 E:735 ||| NN
survey  ||| S:735 E:742 ||| NN
on  ||| S:742 E:745 ||| IN
the  ||| S:745 E:749 ||| DT
acceptability  ||| S:749 E:763 ||| NN
of  ||| S:763 E:766 ||| IN
balloon  ||| S:766 E:774 ||| NN
stent.  ||| S:774 E:781 ||| CD
82.3 ||| S:781 E:785 ||| CD
%  ||| S:785 E:787 ||| NN
of  ||| S:787 E:790 ||| IN
them  ||| S:790 E:795 ||| PRP
could  ||| S:795 E:801 ||| MD
tolerate  ||| S:801 E:810 ||| VB
discomforts  ||| S:810 E:822 ||| VBN
during  ||| S:822 E:829 ||| IN
balloon  ||| S:829 E:837 ||| NN
placement  ||| S:837 E:847 ||| NN
and  ||| S:847 E:851 ||| CC
86.3 ||| S:851 E:855 ||| CD
%  ||| S:855 E:857 ||| NN
desired  ||| S:857 E:865 ||| VBN
re-ballooning  ||| S:865 E:879 ||| JJ
if  ||| S:879 E:882 ||| IN
necessary ||| S:882 E:891 ||| JJ
.  ||| S:891 E:893 ||| .
Positive  ||| S:893 E:902 ||| JJ
microorganism  ||| S:902 E:916 ||| JJ
cultures  ||| S:916 E:925 ||| NNS
were  ||| S:925 E:930 ||| VBD
seen  ||| S:930 E:935 ||| VBN
in  ||| S:935 E:938 ||| IN
17  ||| S:938 E:941 ||| CD
patients  ||| S:941 E:950 ||| NNS
( ||| S:950 E:951 ||| -LRB-
33.3 ||| S:951 E:955 ||| CD
% ||| S:955 E:956 ||| NN
)  ||| S:956 E:958 ||| -RRB-
in  ||| S:958 E:961 ||| IN
balloon  ||| S:961 E:969 ||| NN
group  ||| S:969 E:975 ||| NN
versus  ||| S:975 E:982 ||| IN
8  ||| S:982 E:984 ||| CD
( ||| S:984 E:985 ||| -LRB-
28.6 ||| S:985 E:989 ||| CD
% ||| S:989 E:990 ||| NN
)  ||| S:990 E:992 ||| -RRB-
in  ||| S:992 E:995 ||| IN
intrauterine  ||| S:995 E:1008 ||| JJ
contraceptive  ||| S:1008 E:1022 ||| JJ
device  ||| S:1022 E:1029 ||| NN
group ||| S:1029 E:1034 ||| NN
.  ||| S:1034 E:1036 ||| .
And  ||| S:1036 E:1040 ||| CC
the  ||| S:1040 E:1044 ||| DT
positive  ||| S:1044 E:1053 ||| JJ
rate  ||| S:1053 E:1058 ||| NN
was  ||| S:1058 E:1062 ||| VBD
not  ||| S:1062 E:1066 ||| RB
different  ||| S:1066 E:1076 ||| JJ
between  ||| S:1076 E:1084 ||| IN
two  ||| S:1084 E:1088 ||| CD
groups ||| S:1088 E:1094 ||| NNS
.  ||| S:1094 E:1096 ||| .
It  ||| S:1096 E:1099 ||| PRP
is  ||| S:1099 E:1102 ||| VBZ
relatively  ||| S:1102 E:1113 ||| RB
safe  ||| S:1113 E:1118 ||| JJ
to  ||| S:1118 E:1121 ||| TO
maintain  ||| S:1121 E:1130 ||| VB
the  ||| S:1130 E:1134 ||| DT
intrauterine  ||| S:1134 E:1147 ||| JJ
balloon  ||| S:1147 E:1155 ||| NN
stent  ||| S:1155 E:1161 ||| NN
in  ||| S:1161 E:1164 ||| IN
uterine  ||| S:1164 E:1172 ||| NN
for  ||| S:1172 E:1176 ||| IN
one  ||| S:1176 E:1180 ||| CD
week ||| S:1180 E:1184 ||| NN
.  ||| S:1184 E:1186 ||| .
And  ||| S:1186 E:1190 ||| CC
most  ||| S:1190 E:1195 ||| JJS
patients  ||| S:1195 E:1204 ||| NNS
accept  ||| S:1204 E:1211 ||| VBP
readily  ||| S:1211 E:1219 ||| RB
the  ||| S:1219 E:1223 ||| DT
intrauterine  ||| S:1223 E:1236 ||| JJ
balloon  ||| S:1236 E:1244 ||| NN
stent ||| S:1244 E:1249 ||| NN
.  ||| S:1249 E:1251 ||| .
